Do you feel angry that you’re not eligible for the RSV vaccine? You’re not alone. Read other readers' concerns, and discover how you can get hold of it if you want to pay for it.
The fact that the new RSV vaccination is being offered to people aged 75 to 79, but not to those over 80, has received a stronger response from Saga Magazine readers than any other issue we've covered this year.
The vaccine is potentially lifesaving, especially for older adults. For most people, RSV causes cough and cold symptoms, but for some older adults it can lead to more serious illnesses, including pneumonia. One study estimated that it causes just under 8,000 deaths in over-65s in the UK each year.
More than 1 million people have now had the RSV vaccine on the NHS since it was launched at the beginning of September. The vast majority (around 95%) of those are over-75s, although the figures also include 80,000 pregnant women. The NHS figures also reveal that some people (potentially around 6,000) have managed to get the vaccine without being eligible.
Most people have received the RSV vaccine at their GP, although in some parts of the East of England it is now available through community pharmacies as well. If you are eligible, ask your GP surgery – you don't have to wait to be invited.
RSV is already circulating at higher than usual levels. Steve Russell, NHS national director for vaccinations and screening, said the NHS is trying to avoid a "tripledemic" of Covid, flu and RSV this winter.
“We’ve now delivered millions of vaccinations – with thousands of sites offering Covid and flu jabs together – and have rolled out an RSV vaccination for the first time to help avoid a ‘tripledemic’ this winter – but we’re still urging more people to come forward and make sure they are protected this winter by getting these lifesaving vaccines as soon as possible.”
This week Boots became the first major pharmacy chain to launch a private vaccination service for RSV. It means that people aged over 80 can choose to pay for it if they wish - but the downside is that the cost is £245.
Saga Magazine's GP and columnist, Dr Mark Porter, said: “I have never paid for a vaccine myself and have only had ones for which I have been eligible on the NHS.
"And I wouldn't make an exception for the RSV vaccine because, given the lack of reliable evidence about efficacy, it might not offer the protection that you seek, and also, it is expensive.”
He suggests that those who do decide to go ahead and pay for it, shop around to get the best price.
A few independent pharmacies are offering the vaccine privately, but this doesn't seem to be widespread yet.
The vaccine is available on the NHS for those 75 to 79, as well as women in late pregnancy to protect their babies. But why is it not available for the over-80s? That’s a question many Saga readers asked.
John Battersby, from Hampshire, is particularly upset, since his wife has previously been seriously ill with RSV, and spent 10 days in hospital.
He said: “On her discharge, before the availability of the vaccine, the doctor told her to do her best not to contract another dose of RSV, so we thought (mistakenly) that the newly available vaccine would be a lifesaver, maybe quite literally?
“I was shocked beyond despair that we were met with a blunt refusal to get the vaccine due to being just over the cut-off age. I am absolutely livid.
“There seems to be no valid reason (rather than the very obvious one - cost) other than 'We didn't really look at the over 80's in our trials', which sounds barely credible and deeply shocking to say the very least.”
Helen Penney, 84, said: “I find it appalling to say in one breath that the elderly are particularly vulnerable to this respiratory illness, but then in the next breath say 'but if you are over 79, we won’t be offering it to you'.
“It is the principle that really gets me, that when you turn 80 you are past your sell-by date, of no interest or importance and basically just a nuisance.”
People who were aged 75 to 79 on 1 September are offered it, but that’s no comfort for Saga reader Len Parsons, who had his 80th birthday in June.
“I’m just outside the age range,” he told us. “My neighbour is 78 and he told me he’d just had a text to go for the RSV vaccine and I wondered why my wife and I hadn’t had one. So I got in touch with my surgery, who are very good. But NHS England say I’m not eligible.”
Len was happy to pay for the vaccine, but up until now had difficulty finding anywhere that offered it. He’s written to his local MP, as well as health secretary Wes Streeting, to ask the kinds of questions many people of his age have, including: “Is it for financial or medical reasons?”
Dr Mary Ramsay, Director of Public Health Programmes at the UK Health Security Agency (UKHSA), told Saga: “Based on expert advice from the JCVI, Government decide which groups will be eligible for free NHS vaccines.
"Their decision was based on the latest available evidence at that time, including how long protection lasts and how common RSV infection is within different age groups, and they concluded that there is limited evidence of the vaccine being effective in those aged over 80.
"The JCVI will continue to keep the evidence under review.”
The problem is, there weren't many people over 80 in the trials of the RSV vaccines, which is why there isn't much evidence of how well it works in this age group.
“ We’ve now delivered millions of vaccinations – with thousands of sites offering COVID and flu jabs together – and have rolled out an RSV vaccination for the first time to help avoid a ‘tripledemic’ this winter.” - Steve Russell
The JCVI (Joint Committee on Vaccination and Immunisation) is made up of a group of experts who advise the government on vaccination programmes and they set up a sub-committee to specifically discuss RSV.
The committee advised that people over 75 should be offered the vaccine, with an initial catch-up programme for those aged 75 to 79. The committee did say an extension would be considered once there’s more certainty that the initial vaccinations have had an impact. Making the vaccine available for over-65s is also under review.
A Department of Health and Social Care spokesperson said: “Decisions on eligible groups are guided by the independent Joint Committee on Vaccination and Immunisation’s evidence-based recommendations. The JCVI will continue to review the data on who should be offered an RSV vaccination.”
The RSV vaccine being used in the UK is Abrysvo, a protein subunit vaccine, manufactured by Pfizer. It's the same vaccine whether you get it on the NHS, or privately from a pharmacy like Boots.
It contains isolated proteins from the virus which help the immune system to fight it, but don’t contain any live pathogens (nor is it an mRNA vaccine). The Shingrix vaccine, given to prevent shingles, works in a similar way (although the RSV vaccine is one dose, not two like Shingrix).
One thing stands out: more research is needed on the effects of the RSV vaccine on people who are over 80.
One placebo-controlled trial, of the Moderna RSV vaccine (which is not the vaccine which is being used in the UK, although the JCVI advice is that any of the new RSV vaccines would be suitable), showed that efficacy was “maintained with increasing age”, with people in their 70s seeming to have greater protection after the vaccine than those in their 60s.
So if it’s more effective at 75 than 60, would it be even more so for people who are 80 and older? It’s hard to tell, because only 5.6% of the 35,000 trial participants were over 80, and none of them caught RSV.
The over-75s and over-80s are under-represented in medical research ... part of the issue is reluctance of over-80s to volunteer for the trials, but often they are less likely to be eligible to volunteer or the trial may be designed in a way that’s harder for an older person to take part
Similarly, the trial for the Pfizer vaccine covered 35,000 people and only 5.6% were over 80. Among the 1,928 over-80s in the Pfizer study, five who had been vaccinated caught RSV, compared with 17 who were in the placebo arm.
These figures suggest a higher effectiveness in over-80s than in over-60s or over 70s, but because the numbers are fairly small it is hard to be sure.
Unfortunately, the over-75s and over-80s are under-represented in medical research in general. Only 1.7% of people in Covid vaccine trials were over 75, even though they went on to become one of the first age groups to be vaccinated.
In the past, over-75s were specifically included from many trials, although that has recently changed and the United States has a new law that promotes diversity (of age and other characteristics) in research trials.
Research suggests that part of the issue is reluctance of over-80s to volunteer for the trials, but often they are less likely to be eligible to volunteer (for example because of other health conditions) or the trial may be designed in a way that’s harder for an older person to take part in.
Meanwhile, there is little comfort for over-80s who are left out of the RSV vaccine programme.
Cynthia Lewis, a sculptor from London and a member of the Society of Women Artists, is particularly concerned, since she is classed as very vulnerable for health reasons. She says: “I am not eligible for the free RSV, as I’ve been an octogenarian for some years! I feel that it ought to be based on need and/or vulnerability, not just age.
"As I’m classed as ‘very vulnerable’, perhaps I ought to be eligible, as for over 40 years I haven’t had – and I never will have – a working immune system and I’ve no protection against germs and infections. But the government is not giving us the protection of the RSV vaccine, even though it would be of equal benefit to my age group and to me, so that I can carry on living well, to create my sculptures."
Ivan Holder, 80, from Welwyn Garden City, says: “The RSV vaccine is not a lot of use to me and many other people over 80. It is cut off to save money, and will probably cost a lot more when and if older persons get the illness. It seems to me that when you get old the government wants to not bother with us.”
Caroline Abrahams, Charity Director of Age UK, said: “The risks associated with RSV are less known about for older people. In some older people it may cause symptoms that are much like a cold, but this respiratory virus can also lead to more serious infections such as bronchiolitis or pneumonia.
“We understand that those who are not eligible at the moment may be frustrated. This particular age range aren’t eligible as there isn’t yet enough evidence on the effectiveness in the older age groups. But there may be potential for an extension of eligibility in the future, depending on the outcome of this initial vaccine roll out.”
Get 3 months free, plus a £125 Totally Rewards Wellness Gift Card when you start a new policy by the end of 19 February 2026. T&Cs apply.
Underwritten by Bupa Insurance Limited.
Are you retiring at the wrong age? The best age to retire for your body, brain, happiness and pocket.
Everything you need to know about the lung infection, and how you could be ill with “walking” pneumonia without realising it.
Strong calves for a strong mind: how they support our circulation and brain health, with easy moves to strengthen yours at home.
Our GP Dr Mark Porter explains what can cause itchy skin, which is a common problem as we get older.
Worried you’ve morphed into Victor Meldrew? Find out how to battle that bad mood, and what to do if you’re stuck with a grouchy loved one.
The benefits of heat and cold therapy, and how Nordic bathing won over our nervous writer.
Here’s how to spot the symptoms of heat disease and reduce your danger.
The NHS winter vaccination campaign kicks off next week. Here’s the lowdown on what you need to book.
Pilates for back pain – what to do if you are suffering, and five gentle exercises that could help.
Dizziness or vertigo: a sensation of spinning, can stop us doing everyday things for fear of falling. Try these tips to stop feeling dizzy
You don’t have to put up with bladder leaks. We try out the latest pelvic floor gadgets for men and women.
Cataracts are a normal part of ageing. Learn how to spot the signs – and when it’s time to consider surgery.
